Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

SHE:300601 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	219.94	432.84	1,196	1,018	3,550	882.69
Short-Term Investments	-	2,174	463.34	531.58	725.57	-
Trading Asset Securities	-	-	100.02	440.83	-	2,155
Cash & Short-Term Investments	219.94	2,607	1,759	1,990	4,275	3,038
Cash Growth	-77.94%	48.21%	-11.61%	-53.45%	40.73%	501.29%
Accounts Receivable	2,863	2,787	2,788	2,293	1,858	1,613
Other Receivables	8.58	10.54	8.9	11.38	14.25	59.09
Receivables	2,872	2,798	2,797	2,305	1,872	1,672
Inventory	726.16	782.77	772.85	727.8	1,058	436.55
Other Current Assets	2,412	55.09	67.51	152.34	135.14	197.71
Total Current Assets	6,230	6,242	5,396	5,175	7,341	5,345
Property, Plant & Equipment	5,156	5,225	5,716	5,176	4,116	2,279
Long-Term Investments	-	-	311.68	302.38	105.64	101.71
Other Intangible Assets	427.58	436.66	433.45	357.98	346.04	294.36
Long-Term Deferred Tax Assets	693.04	697.63	630.32	708.32	558.6	702.05
Long-Term Deferred Charges	275.08	268.26	172.47	195.95	489.6	195.57
Other Long-Term Assets	1,473	1,693	2,425	1,871	1,192	667.18
Total Assets	14,255	14,564	15,085	13,786	14,149	9,585
Accounts Payable	709.84	847.83	882.48	434.13	708.2	167.36
Accrued Expenses	39.66	1,358	1,595	1,330	807.26	798.67
Short-Term Debt	35.61	34.1	60.04	170.07	777.53	11.32
Current Portion of Long-Term Debt	111.17	202.95	32.32	103.61	22.6	12.07
Current Income Taxes Payable	14.58	6.32	-	-	65.64	-
Current Unearned Revenue	20.08	19.28	28.76	31.23	94.51	14.95
Other Current Liabilities	1,397	178.17	152.69	270.96	142.39	751.57
Total Current Liabilities	2,327	2,647	2,751	2,340	2,618	1,756
Long-Term Debt	1,807	1,786	2,372	2,016	1,938	67.8
Long-Term Unearned Revenue	251.05	247.82	328.7	383.1	349.54	278.5
Long-Term Deferred Tax Liabilities	34.48	34.52	26.89	26.08	41.47	18.83
Other Long-Term Liabilities	151.28	186.72	64.51	36.33	35.13	-
Total Liabilities	4,572	4,903	5,544	4,801	4,982	2,121
Common Stock	1,117	1,117	1,117	1,120	687.09	684.93
Additional Paid-In Capital	5,511	5,511	5,369	5,490	5,357	5,265
Retained Earnings	2,545	2,523	2,544	1,884	2,612	1,555
Treasury Stock	-	-	-	-20	-0.55	-41.55
Comprehensive Income & Other	510.9	510.95	511.1	511.14	511.3	-
Total Common Equity	9,684	9,661	9,542	8,985	9,167	7,463
Minority Interest	-0.15	-0.1	-	-	-	-
Shareholders' Equity	9,683	9,661	9,542	8,985	9,167	7,463
Total Liabilities & Equity	14,255	14,564	15,085	13,786	14,149	9,585
Total Debt	1,954	2,024	2,465	2,289	2,738	91.19
Net Cash (Debt)	-1,734	583.32	-705.64	-299.34	1,537	2,947
Net Cash Growth	-	-	-	-	-47.84%	1082.44%
Net Cash Per Share	-1.53	0.52	-0.63	-0.27	1.38	2.74
Filing Date Shares Outstanding	1,117	1,117	1,117	1,120	1,120	1,096
Total Common Shares Outstanding	1,117	1,117	1,117	1,120	1,099	1,096
Working Capital	3,902	3,595	2,645	2,835	4,723	3,589
Book Value Per Share	8.67	8.65	8.54	8.02	8.34	6.81
Tangible Book Value	9,256	9,224	9,108	8,627	8,821	7,169
Tangible Book Value Per Share	8.29	8.26	8.15	7.70	8.02	6.54
Buildings	-	2,780	2,718	1,037	939.37	859.63
Machinery	-	2,840	1,853	1,671	1,682	731.24
Construction In Progress	-	990.28	2,281	3,463	2,320	1,136

Source: S&P Global Market Intelligence. Standard template. Financial Sources.